Get the Stockscreener App
1.785
5.62%
0.095
After Hours:
1.81
0.025
+1.40%
Palisade Bio Inc stock is traded at $1.785, with a volume of 6.39M.
It is up +5.62% in the last 24 hours and down -2.99% over the past month.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
See More
Previous Close:
$1.69
Open:
$1.73
24h Volume:
6.39M
Relative Volume:
0.82
Market Cap:
$266.33M
Revenue:
-
Net Income/Loss:
$-14.07M
P/E Ratio:
-0.1276
EPS:
-13.99
Net Cash Flow:
$-12.56M
1W Performance:
-19.96%
1M Performance:
-2.99%
6M Performance:
+148.78%
1Y Performance:
-13.35%
1-Day Range:
$1.69
$1.86
1-Week Range:
$1.65
$2.255
52-Week Range:
$0.53
$3.30
Palisade Bio Inc Stock (PALI) Company Profile
Name
Palisade Bio Inc
Sector
Industry
Phone
(858) 704-4900
Address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Compare PALI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
1.785 | 252.15M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Palisade Bio Inc Stock (PALI) Latest News
Palisade Bio increases authorized common shares following stockholder approval By Investing.com - Investing.com India
Palisade Bio increases authorized common shares following stockholder approval - Investing.com
Is Palisade Bio Inc. stock a buy before product launchesEarnings Beat & Weekly High Conviction Trade Ideas - Newser
How Palisade Bio Inc. (7NS0) stock correlates with oil markets2025 Top Decliners & Fast Gain Swing Trade Alerts - Newser
Will Palisade Bio Inc. stock beat EPS estimates2025 Fundamental Recap & Weekly Momentum Stock Picks - Newser
Will Palisade Bio Inc. (7NS0) stock profit from AI boomGlobal Markets & Reliable Intraday Trade Plans - Newser
Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development - markets.businessinsider.com
Palisade Bio appoints James Izanec as VP of clinical development - Investing.com
Palisade Bio Appoints Dr. James Izanec as Vice President of Clinical Development - Quiver Quantitative
Palisade Bio strengthens clinical leadership team with appointment of James Izanec - marketscreener.com
Palisade Bio Strengthens Clinical Leadership Team with - GlobeNewswire
Is Palisade Bio Inc. stock ready for breakoutStop Loss & Accurate Entry/Exit Alerts - Newser
Can Palisade Bio Inc. stock weather global recession2025 Price Momentum & Short-Term Trading Alerts - Newser
Will Palisade Bio Inc. (7NS0) stock announce special dividendJuly 2025 Short Interest & Capital Efficiency Focused Strategies - Newser
What is Palisade Bio Inc (PALI) Stock Return on Shareholders’ Capital? - Setenews
How geopolitical risks impact Palisade Bio Inc. (7NS0) stockMarket Growth Report & Free Real-Time Volume Trigger Notifications - BỘ NỘI VỤ
Is Palisade Bio Inc. stock a good choice for value investorsMarket Trend Summary & Technical Buy Zone Confirmation - BỘ NỘI VỤ
Palisade Bio Inc. (PALI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What is the Price Targets for Palisade Bio Inc (PALI)? - fostersleader.com
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire
The time has not yet come to remove your chips from the table: Palisade Bio Inc (PALI) - Setenews
What analysts say about Palisade Bio Inc stockStock Liquidity Analysis & Tap Into the Fastest-Growing Companies - earlytimes.in
How big funds are accumulating Palisade Bio Inc. (7NS0) stockJuly 2025 Pullbacks & High Accuracy Investment Signals - newser.com
How Palisade Bio Inc. stock performs after earnings2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
Can Palisade Bio Inc. stock attract ESG capital inflowsWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com
Individual investors are Palisade Bio, Inc.'s (NASDAQ:PALI) biggest owners and were rewarded after market cap rose by US$70m last week - Yahoo Finance
Free cash flow per share of Palisade Bio, Inc. – FWB:7NS0 - TradingView
Using RSI to spot recovery in Palisade Bio Inc.2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Will Palisade Bio Inc. stock deliver consistent dividendsMarket Rally & Weekly High Return Opportunities - newser.com
Will Palisade Bio Inc. (7NS0) stock deliver compounding returnsM&A Rumor & Real-Time Sentiment Analysis - newser.com
Using data filters to optimize entry into Palisade Bio Inc.2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Why Palisade Bio Inc. (7NS0) stock is upgraded to buy - newser.com
Why Palisade Bio Inc. stock could be next big winnerRisk Management & Fast Moving Market Watchlists - newser.com
What MACD and RSI say about Palisade Bio Inc.2025 Market Sentiment & Daily Profit Focused Screening - newser.com
Why Palisade Bio Inc. stock remains resilientEarnings Overview Report & Low Drawdown Trading Techniques - newser.com
Will Palisade Bio Inc. stock deliver better than expected guidanceJuly 2025 Summary & Technical Pattern Based Buy Signals - newser.com
Palisade Bio Inc Stock (PALI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):